Correlation of atherosclerosis between different topographic sites is highly dependent on the type of hyperlipidemia

Eline Van Craeyveld1, Stephanie C Gordts, Frank Jacobs

  • 1Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium.

Heart and Vessels
|January 27, 2011
PubMed

Insights

The correlation of atherosclerosis extent across different aortic sites varies significantly with hyperlipidemia type. This study highlights how lipid profiles influence atherosclerosis progression at specific locations.

Area of Science:

  • Cardiovascular Research
  • Atherosclerosis Pathogenesis
  • Lipid Metabolism

Background:

  • Quantitative data on atherosclerosis extent across different topographic sites is limited.
  • Cardiovascular risk factors impact atherosclerosis progression in a site-selective manner.
  • The correlation of atherosclerosis between sites may depend on individual cardiovascular risk profiles.

Purpose of the Study:

  • To investigate if the correlation of atherosclerosis extent between different topographic sites is influenced by the type of hyperlipidemia.
  • To evaluate site-specific atherosclerosis progression in relation to hyperlipidemia subtypes.

Main Methods:

  • Atherosclerosis was quantified in four aortic locations in rabbits with type II or type III hyperlipidemia.
  • Correlation and semi-partial correlation coefficients were calculated, adjusting for plasma lipoproteins and sex.
  • Intima/media ratios were analyzed to compare atherosclerosis degree at different topographic sites.

Main Results:

  • Semi-partial correlations of atherosclerosis extent between aortic sites were highly dependent on hyperlipidemia type.
  • A strong correlation (0.87) was observed between ascending and descending aorta in type II hyperlipidemia, versus a weak correlation (0.10) in type III.
  • These divergent patterns were consistent across other intersite correlations.

Conclusions:

  • The correlation of atherosclerosis extent between different topographic sites varies significantly based on the type of hyperlipidemia.
  • Hyperlipidemia type is a critical factor influencing the site-selective progression of atherosclerosis.
  • Findings underscore the importance of considering lipid profiles in understanding atherosclerosis distribution.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview